Antibiotics General Structure/MOA Flashcards
PCN General Structure
Beta-Lactam Ring; Thiazolidine Ring; Acyl Side Chain
Beta-Lactam Ring; Thiazolidine Ring; Acyl Side Chain
PCN General Structure
PCN MOA
Inhibits Cell Wall Formation
PCN Mechanism of Resistance
Enzyme inactivation - Beta-Lactamase
Altered PCN binding Proteins (PBPs)
What are the three clinical issues for PCNs
1) Dose adjustment needed for renal d/o
2) Strep pneumo is becoming increasingly resistant
3) Time above MIC is critical to PCN success. 50% of the time the level needs to be above MIC.
Cephalosporin General Structure
Beta-Lactam Ring; Dihydrothiazine Ring; Acyl Side Chain
Beta-Lactam Ring; Dihydrothiazine Ring; Acyl Side Chain
Cephalosporin General Structure
Cephalosporin MOA
Binds to PBPs and interferes with cell wall synthesis (similar to PCNs)
Cephalosporin Mechanism of Resistance
Enzyme inactivation - Beta-Lactamse
Altered PCN binding Proteins (PBPs)
What are the three clinical issues with Cephalosporins?
1) Most require dosing adjustment for renal failure (not ceftriaxone)
2) Resistance is increasing
3) Need double coverage for Pseudomonas
General Structure for Carbapenems.
Beta-Lactam ring; Cabapenem Ring
What are the Mechanisms of Resistance for Carbapenems?
Pseudomonas has shown altered permability to Imipenem.
Antagonism has been seen when Imipenem is used with other Beta-Lactams due to increased Beta-Lactamase production
Mechanism of Action for Monobactams
Binds to PBPs and therefore inhibits cell wall formation
Mechanism of Action for Vancomycin
Inhibits bacterial cell wall synthesis at earlier step than the Beta-Lactams
Oxazolidinoe MOA
Protein Synthesis Inhibitor